National Foundation for Ectodermal Dysplasias

Our mission is to empower and connect people touched by
ectodermal dysplasias through education, support, and research.

CALL US AT (618) 566-2020

We're here to help

Research News

Q and A from XLHED Women’s Day 2014

August 14, 2014

Edimer Pharmaceuticals hosted the XLHED Women's Day in Columbus in conjunction with the NFED Family Conference. Following is a Q and A from that event. 

Read More »

Answering Your Questions about the Adults with XLHED Study

November 28, 2012

Participants asked the following questions on a webinar that the NFED hosted in August regarding Edimer Pharmaceuticals’ Adults with XLHED Study. Edimer provided the answers. To read more of the Q and A and listen to the webinar, go to our website under research news.

Read More »

Women’s Survey Results Help Us Understand Female-Specific Issues

November 28, 2012

The results are in! The NFED sponsored a survey to further characterize female-specific issues and their possible connection to ectodermal dysplasias.

Read More »

Studying Focal Dermal Hypoplasia Using Stem Cells

November 28, 2012

We have collected skin biopsies from five individuals with Goltz syndrome and are awaiting an additional four biopsies. After several weeks of growing these skin biopsies in a dish in the laboratory we obtained several million cells, some of which we have frozen for long-term storage. 

Read More »

Goltz Families Needed to Participate in Major Research Conference

November 28, 2012

In 2013, we will sponsor a research conference dedicated to Goltz syndrome in conjunction with Baylor College of Medicine & Texas Children's Hospital. 

Read More »

Characterization of A Novel Conditional Mouse Model For AEC Syndrome

November 28, 2012

AEC syndrome is caused by mutations in the p63 gene, encoding for a protein that plays an essential role in early development. The p63 protein is a transcription factor, which means that it attaches (binds) to DNA and controls the activity of several genes involved in development of several ectodermal structures, such as the skin, hair, teeth, nails, and also the palate epithelium. The p63 gene mutations responsible for AEC syndrome interfere with the ability of p63 to turn target genes on and off at the right times.

Read More »

Toward A Cure for Skin Erosions in AEC Patients

November 28, 2012

Ankyloblepharon ectodermal dysplasia and clefting (AEC) syndrome is an ectodermal dysplasia characterized by skin fragility, often causing the skin to erode. Currently, there is no cure for skin erosions in AEC patients. Our goal is to develop a novel approach for treating skin erosions in AEC patients. 

Read More »

Edimer Adult Safety Trials

October 08, 2012

The NFED and Edimer Pharmaceuticals hosted a webinar this fall to explain the Adult Safety Trials

Read More »

Prevalence of Atopic Disorders and Immunodeficiency in Patients with Ectodermal Dysplasia Syndromes

June 14, 2012

 


 
Read this published study completed with the help of our NFED families. This study would not have been possible with out the response from these families and their willingness to share information.  This study focuses on allergies and eczema as they relate to ectodermal dysplasias.

 

Read More »

30 Years of Research Success

March 01, 2012

Connecting Lives 

Download and read this progress report celebrating the NFED's 30 years of ectodermal dysplasias research success.

Read More »

Page 1 of 2 pages  1 2 > 

Site Copyright 2010 by National Foundation for Ectodermal Dysplasias. All Rights Reserved. St. Louis web design by Insite Advice.
The National Foundation for Ectodermal Dysplasias (NFED) is a qualified 501(c)(3) nonprofit organization.
The EIN is 37-1112496. The NFED is registered in all states where applicable.
6 Executive Dr., Ste. 2, Fairview Heights, IL 62208-1360